Sundry Photography/iStock Editorial via Getty Images Listen below or on the go on Apple Podcasts and Spotify Margin worries lead to selling of another big AI trade name. (0:15) Pot stocks pop. (1:16) Bud closing breweries. (2:07) The following is an abridged transcript: The AI trade hit another speed bump, with Broadcom (AVGO) under pressure post-earnings on margin concerns. Deutsche Bank’s Jim Reid noted that after a 78% YTD rally, Broadcom now has a larger market cap than Meta and Tesla, underscor ...

Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to push the government to dramatically loosen federal restrictions on marijuana. ...

U.S. stock futures swung between gains and losses on Friday after Thursday’s mixed close. Futures of major benchmark indices were mixed.Thursday experienced a rotation out of expensive tech names, which helped U.S. stocks settle mostly higher, with the Dow Jones surging over 600 points. Overall risk appetite remained resilient following the Federal Reserve's third consecutive interest-rate cut delivered a day earlier. Meanwhile, President Donald Trump signed a sweeping executive order aimed at creating a si ...

Canopy Growth stock price staged a strong comeback in the pre-market session as investors cheered the latest news on cannabis rescheduling. CGC jumped by over 35% to $1.530, pushing its market cap to ... ...

Cronos Group Inc. (NASDAQ:CRON) is one of the best long-term penny stocks to invest in. Cronos Group Inc. (NASDAQ:CRON) announced on December 9 that its wholly-owned subsidiary entered into a definitive share sale and purchase agreement for the acquisition of all the outstanding shares of CanAdelaar B.V., which is the largest cannabis company in operation in the adult-use cannabis pilot program (the Wietexperiment) in the Netherlands. Is Cronos Group Inc. (CRON) The Best CBD Stock To Invest In Right Now? ...

Top Cannabis Stocks for Traders This Week: Industry Stats and Technical LevelsThe U.S. cannabis market continues to shift quickly as new states expand access and more consumers enter the legal marketplace. Investors are watching major multi-state operators closely, especially as competitive pressure increases. December often brings renewed attention to companies with strong retail footprints and improving financial performance. As the sector matures, companies with scale and discipline stand out. These firm ...

Latest Innovation Brings New Proprietary Cultivar to Polish Patients Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Raf, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include Cannabis flos Aurora 27/1, MedReleaf, C ...

TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, announces the launch of Amped Live Resin Liquid Diamond 1g 510 cartridges, marking Redecan’s first live resin–liquid diamond line for the brand. The debut lineup, Space Age CK and Blueberry DNTS, pairs Redecan’s Legit Live Resin with Liquid Diamonds to deliver a true‑to‑strain flavour an ...

Tilray Brands Inc (NASDAQ:TLRY) experiences a significant stock price recovery, surging over 12% after a challenging period.The company underwent a 1-for-10 reverse stock split, reducing its float and potentially contributing to recent stock price movements.Tilray's market capitalization stands at approximately $924.94 million, with a year of high volatility, indicating the dynamic nature of the cannabis industry.Tilray Brands Inc (NASDAQ:TLRY) is a prominent player in the cannabis industry, known for its p ...

公司董事会变动 - Shelley Potts将于2025年12月31日从公司董事会卸任 她自2020年起担任董事 在公司早期动荡时期帮助引导了稳定增长 并一直是良好公司治理和审慎财务纪律的坚定倡导者 [1][3] - Michael Bumby将于2026年1月1日重新加入董事会 他曾担任VIVO Cannabis Inc首席财务官 并在全球制药公司担任高级领导职务 在高度监管的市场拥有战略和财务监督经验 [1][2] - 董事会主席表示 Michael Bumby的财务专长以及之前在VIVO和MediPharm的经验将为董事会提供额外的深度和视角 [3] 公司业务与战略 - MediPharm Labs成立于2015年 专注于开发和生产纯化的、制药级的大麻浓缩物、活性药物成分(API)和先进衍生产品 其设施获得GMP认证并配备ISO标准洁净室 [4] - 公司于2021年从加拿大卫生部获得了制药企业许可证 成为北美唯一一家拥有商业规模国内GMP许可证 可用于提取多种天然大麻素的公司 该许可证是公司当前向美国FDA注册外国药品生产基地的第一步 [5] - 2023年 公司收购了VIVO Cannabis Inc 此次收购扩大了公司在加拿大通过Canna Farms医疗电商平台 以及在澳大利亚和德国通过Beacon Medical PTY和Beacon Medical GMBH对医疗患者的覆盖 收购还包括加拿大的Harvest Medical Clinics 该诊所为患者提供医生咨询、医疗大麻教育和处方服务 [6]